The price of TC Biopharm (Holdings) Plc (NASDAQ:TCBP) shares last traded on Wall Street rose 19.74% to $0.82.
Based on available information, 1 analysts follow TC Biopharm (Holdings) Plc (NASDAQ:TCBP). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $5.61 and a low of $5.61, we find $5.61. Given the previous closing price of $0.68, this indicates a potential upside of 725.0 percent. TCBP stock price is now 33.62% away from the 50-day moving average and -76.88% away from the 200-day moving average. The market capitalization of the company currently stands at $1.79M.
Among analysts, 0 rate the stock a hold while 1 rate it a buy. Brokers who have rated the stock have averaged $5.61 as their price target over the next twelve months.
In other news, Randall Diana Elizabeth, 10% Owner bought 70,000 shares of the company’s stock on Nov 30. The stock was bought for $350,000 at an average price of $5.00. Upon completion of the transaction, the 10% Owner now directly owns 70,000 shares in the company, valued at $57400.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 30, 10% Owner Randall Kenneth Edward bought 70,000 shares of the business’s stock. A total of $350,000 was incurred on buying the stock at an average price of $5.00. This leaves the insider owning 382,963 shares of the company worth $0.31 million. A total of 11.74% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in TCBP stock. A new stake in TC Biopharm (Holdings) Plc shares was purchased by VIRTU FINANCIAL LLC during the first quarter worth $10,000. WELLS FARGO & COMPANY/MN invested $6,000 in shares of TCBP during the first quarter. In the first quarter, STEWARD FINANCIAL GROUP LLC acquired a new stake in TC Biopharm (Holdings) Plc valued at approximately $2,000.
A candlestick chart of TC Biopharm (Holdings) Plc (NASDAQ: TCBP) showed a price of $0.8586 on Thursday morning. During the past 12 months, TC Biopharm (Holdings) Plc has had a low of $0.42 and a high of $22.00. The fifty day moving average price for TCBP is $0.6139 and a two-hundred day moving average price translates $3.4957 for the stock.
The latest earnings results from TC Biopharm (Holdings) Plc (NASDAQ: TCBP) was released for Dec, 2022. The net profit margin was -36.10% and return on equity was 19.70% for TCBP.
